MIRA Earnings

Quarterly EPS
$-0.14
Q3 2024
$-0.14
Q4 2024
$-0.11
Q1 2025
$-0.09
Q2 2025
$-1.18
Q3 2025
$-0.14
Q4 2025
$-0.03
Q1 2026
$-0.03
Q2 2026
Latest RevenueN/A
Latest Net Income-1208534
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.030-1208534+66.7%
Q1 2026-$0.030-1150152+72.7%
Q4 2025-$0.140-5983321+0.0%
Q3 2025-$1.180-1137673-742.9%
Q2 2025-$0.090-1537712+18.2%
Q1 2025-$0.110-1783779+26.7%
Q4 2024-$0.140-2399696+73.6%
Q3 2024-$0.140-2043867+46.2%
Q2 2024-$0.110-1691325
Q1 2024-$0.150-1717771
Q4 2023-$0.530-5787378
Q3 2023-$0.260-3587816
MIRA Pharmaceuticals (MIRA) — Earnings